Mutation of single murine acetylcholine receptor subunits reveals differential contribution of P121 to acetylcholine binding and channel opening.,
Peter C,Korngreen A,Witzemann V,
Pflugers Arch. June 1, 2005; 450(3):1432-2013.
|
Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2).,
Gao B,Sekido Y,Maximov A,Saad M,Forgacs E,Latif F,Wei MH,Lerman M,Lee JH,Lee JH,Perez-Reyes E,Bezprozvanny I,Minna JD,
J Biol Chem. April 21, 2000; 275(16):1083-351X.
|
Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction.,
Gomez CM,Maselli R,Gundeck JE,Chao M,Day JW,Tamamizu S,Lasalde JA,McNamee M,Wollmann RL,
J Neurosci. June 1, 1997; 17(11):1529-2401.
|
A transgenic mouse model of the slow-channel syndrome.,
Gomez CM,Bhattacharyya BB,Charnet P,Day JW,Labarca C,Wollmann RL,Lambert EH,
Muscle Nerve. January 1, 1996; 19(1):1097-4598.
|
Potential role of caveolin-1-positive domains in the regulation of the acetylcholine receptor's activatable pool: implications in the pathogenesis of a novel congenital myasthenic syndrome.,
Báez-Pagán CA,Martínez-Ortiz Y,Otero-Cruz JD,Salgado-Villanueva IK,Velázquez G,Ortiz-Acevedo A,Quesada O,Silva WI,Lasalde-Dominicci JA,
Channels (Austin). January 1, 2008; 2(3):1933-6969.
|
Acetylcholine receptor gating in a zebrafish model for slow-channel syndrome.,
Walogorsky M,Mongeon R,Wen H,Mandel G,Brehm P,
J Neurosci. June 6, 2012; 32(23):1529-2401.
|
Using Xenopus tissue cultures for the study of myasthenia gravis pathogenesis.,
Yeo HL,Lim JY,Fukami Y,Yuki N,Lee CW,Lee CW,Lee CW,
Dev Biol. December 15, 2015; 408(2):1095-564X.
|
Using Xenopus to understand human disease and developmental disorders.,
Sater AK,Moody SA,
Genesis. January 1, 2017; 55(1-2):1526-968X.
|
Grp94 Regulates the Recruitment of Aneural AChR Clusters for the Assembly of Postsynaptic Specializations by Modulating ADF/Cofilin Activity and Turnover.,
Chan ZC,Deng L,Lee CW,Lee CW,Lee CW,
eNeuro. September 8, 2020; 7(5):2373-2822.
|
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery.,
O'Connor EC,Kambara K,Bertrand D,
Expert Opin Drug Discov. February 1, 2024; 19(2):1746-045X.
|